The DOI matches its Crossref record; 492 of the 492 references it cites were found in a registry or an index.
Pharmacological Actions of Statins: A Critical Appraisal in the Management of Cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–400 of 492
Statin Use and the Risk of 10 Cancers
Coogan, P. F., Rosenberg, L., & Strom, B. L. (2007) · Epidemiology · doi:10.1097/01.ede.0000254694.03027.a1 · Cited by 162
Patients with acute coronary syndromes express enhanced CD40 ligand/CD154 on platelets
Garlichs, C. D., Eskafi, S., Raaz, D., Schmidt, A., Ludwig, J., Herrmann, M., Klinghammer, L., Daniel, W. G., & Schmeisser, A. (2001) · Heart · doi:10.1136/heart.86.6.649 · Cited by 162
Kalmijn, S., Feskens, E. J. M., Launer, L. J., & Kromhout, D. (1996) · Stroke · doi:10.1161/01.str.27.12.2230 · Cited by 160
Ifergan, I., Wosik, K., Cayrol, R., Kébir, H., Auger, C., Bernard, M., Bouthillier, A., Moumdjian, R. A., Duquette, P., & Prat, A. (2006) · Annals of Neurology · doi:10.1002/ana.20875 · Cited by 158
Simvastatin enhances learning and memory independent of amyloid load in mice
Li, L., Cao, D., Kim, H., Lester, R. A. J., & Fukuchi, K. (2006) · Annals of Neurology · doi:10.1002/ana.21053 · Cited by 156
Ganesan, A., Crum‐Cianflone, N. F., Higgins, J. M., Qin, J., Rehm, C. A., Metcalf, J. A., Brandt, C., Vita, J., Decker, C. F., Sklar, P. A., et al. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiq115 · Cited by 156
Ghittoni, R., Patrussi, L., Pirozzi, K., Pellegrini, M., Lazzerini, P. E., Capecchi, P. L., Pasini, F. L., & Baldari, C. T. (2005) · The FASEB Journal · doi:10.1096/fj.04-2702fje · Cited by 154 · cited 1×
“Simvastatin suppresses T-cell activation and proliferation by selectively impairing the Ras/MAPK pathway (Ghittoni et al., 2005).”
BackgroundRacchi, M., Baetta, R., Salvietti, N., Ianna, P., Franceschini, G., Paoletti, R., Fumagalli, R., Govoni, S. M., Trabucchi, M., & Soma, M. R. (1997) · Biochemical Journal · doi:10.1042/bj3220893 · Cited by 154
Preclinical pharmacokinetics of statins
Reinoso, R. F., Sanchez Navarro, A., Garcia, M. J., & Prous, J. (2002) · Methods and Findings in Experimental and Clinical Pharmacology · doi:10.1358/mf.2002.24.9.802312 · Cited by 154
Lipid-Lowering Drug Use and Breast Cancer in Older Women: A Prospective Study
Cauley, J. A., Zmuda, J. M., Lui, L., Hillier, T. A., Ness, R. B., Stone, K. L., Cummings, S. R., & Bauer, D. C. (2003) · Journal of Women s Health · doi:10.1089/154099903322447710 · Cited by 154
Atorvastatin prevents RhoC isoprenylation, invasion, and metastasis in human melanoma cells.
Collisson, E. A., Kleer, C. G., Wu, M., De, A., Gambhir, S. S., Merajver, S. D., & Kolodney, M. S. (2003) · PubMed · Cited by 151
Ito, K., Ogihara, K., Kanamitsu, S.-I., & Itoh, T. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.7.945 · Cited by 151
Atheroprotective Signaling Mechanisms Activated by Steady Laminar Flow in Endothelial Cells
Berk, B. C. (2008) · Circulation · doi:10.1161/circulationaha.107.720730 · Cited by 150
Prelamin A Farnesylation and Progeroid Syndromes
Young, S. G., Meta, M. D., Yang, S. H., & Fong, L. G. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.r600033200 · Cited by 150
Fischer, V., Johanson, L., Heitz, F., Tullman, R. H., Graham, E., Baldeck, J. P., & Robinson, W. T. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)14919-7 · Cited by 149
Bifulco, M., Laezza, C., Stingo, S., & Wolff, J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.042678799 · Cited by 147
Self-citationBrunner, T. B., Hahn, S. M., Gupta, A., Muschel, R. J., McKenna, W. G., & Bernhard, E. J. (2003) · PubMed · Cited by 147
Comparative Pharmacokinetics and Pharmacodynamics of Pravastatin and Lovastatin
Pan, H., DeVault, A. R., Wang‐Iverson, D. B., Ivashkiv, E., Swanson, B. N., & Sugerman, A. A. (1990) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1990.tb01856.x · Cited by 146
Hristov, M., Fach, C., Becker, C., Heussen, N. M., Liehn, E. A., Blindt, R., Hanrath, P., & Weber, C. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.05.031 · Cited by 146
Serum Cholesterol and Cancer Risk: An Epidemiologic Persepective
Kritchevsky, S. B., & Kritchevsky, D. (1992) · Annual Review of Nutrition · doi:10.1146/annurev.nu.12.070192.002135 · Cited by 146
Medina, M. W., Gao, F., Ruan, W., Rotter, J. I., & Krauss, R. M. (2008) · Circulation · doi:10.1161/circulationaha.108.773267 · Cited by 144
Hsyu, P., Schultz-Smith, M. D., Lillibridge, J. H., Lewis, R. H., & Kerr, B. M. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.12.3445-3450.2001 · Cited by 144
Prevention of stroke and dementia with statins
Vaughan, C. J. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)03270-8 · Cited by 143
A Phase I-II Trial of Lovastatin for Anaplastic Astrocytoma and Glioblastoma Multiforme
Larner, J. M., Jane, J., Laws, E. R., Packer, R. J., Myers, C. E., & Shaffrey, M. E. (1998) · American Journal of Clinical Oncology · doi:10.1097/00000421-199812000-00010 · Cited by 142
Structure of mammalian protein geranylgeranyltransferase type‐I
Taylor, J. S., Reid, T. S., Terry, K. L., Casey, P. J., & Beese, L. S. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg571 · Cited by 142
Benini, S., Manara, M. C., Baldini, N., Cerisano, V., Serra, M., Mercuri, M., Lollini, P., Nanni, P., Picci, P., & Scotlandi, K. (2001) · PubMed · Cited by 141
Bonovas, S., Filioussi, K., Flordellis, C. S., & Sitaras, N. M. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.10.8936 · Cited by 141
Yılmaz, A., Reiss, C., Tantawi, O., Weng, A., Stumpf, C., Raaz, D., Ludwig, J., Berger, T. G., Steinkasserer, A., Daniel, W. G., et al. (2003) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2003.10.002 · Cited by 141
Stanislaus, R., Singh, A. K., & Singh, I. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.1207 · Cited by 140
Mandal, C. C., Ghosh-Choudhury, N., Yoneda, T., Choudhury, G. G., & Ghosh-Choudhury, N. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.193714 · Cited by 138
Phase II Study of High-Dose Lovastatin in Patients with Advanced Gastric Adenocarcinoma
Kim, W. S., Kim, M. M., Choi, H. J., Yoon, S., Lee, M. H., Park, K., Park, C. H., & Kang, W. K. (2001) · Investigational New Drugs · doi:10.1023/a:1006481423298 · Cited by 137
Statin Use and the Risk of Breast and Prostate Cancer
Coogan, P. F., Rosenberg, L. A., Palmer, J. R., Strom, B. L., Zauber, A. G., & Shapiro, S. (2002) · Epidemiology · doi:10.1097/00001648-200205000-00005 · Cited by 137
Kornblau, S. M., Banker, D. E., Stirewalt, D. L., Shen, D. D., Lemker, E., Verstovšek, S., Estrov, Z. E., Faderl, S. H., Cortes, J. E., Beran, M., et al. (2006) · Blood · doi:10.1182/blood-2006-08-044446 · Cited by 136
Bettermann, K., Arnold, A. M., Williamson, J. D., Rapp, S. R., Sink, K. M., Toole, J. F., Carlson, M. C., Yaşar, S., DeKosky, S. T., & Burke, G. L. (2011) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2010.11.002 · Cited by 135
Targeting Low HDL-Cholesterol to Decrease Residual Cardiovascular Risk in the Managed Care Setting
Cziraky, M. J., Watson, K. E., & Talbert, R. L. (2008) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2008.14.s8-a.1 · Cited by 134
Feleszko, W., Młynarczuk-Biały, I., Bałkowiec-Iskra, E., Czajka, A., Świtaj, T., Stokłosa, T., Giermasz, A., & Jakóbisiak, M. (2000) · PubMed · Cited by 134
Role of RhoA Inactivation in Reduced Cell Proliferation of Human Airway Smooth Muscle by Simvastatin
Takeda, N., Kondo, M., Ito, S., Ito, Y., Shimokata, K., & Kume, H. (2006) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2006-0034oc · Cited by 133
Antiplatelet Actions of Statins and Fibrates Are Mediated by PPARs
Ali, F. Y., Armstrong, P. C. J., Dhanji, A., Tucker, A. T., Paul‐Clark, M. J., Mitchell, J. A., & Warner, T. D. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.183160 · Cited by 133
Myeloproliferative stem cell disorders by deregulated Rap1 activation in SPA-1-deficient mice
Ishida, D., Kometani, K., Yang, H., Kakugawa, K., Masuda, K., Iwaï, K., Suzuki, M., Itohara, S., Nakahata, T., Hiai, H., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00163-6 · Cited by 133
He, H., Dai, F., Yu, L., She, X., Zhao, Y. B., Jiang, J., Chen, X., & Zhao, S. (2002) · Gene Expression · doi:10.3727/000000002783992406 · Cited by 132
Familial Cancer Associated with a Polymorphism inARLTS1
Calin, G. A., Trapasso, F., Shimizu, M., Dumitru, C. D., Yendamuri, S., Godwin, A. K., Ferracin, M., Bernardi, G., Chatterjee, D., Baldassarre, G., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042280 · Cited by 132
Bouterfa, H., Sattelmeyer, V., Czub, S., Vordermark, D., Roosen, K., & Tonn, J. (2000) · PubMed · Cited by 131
Inhibition of cell growth by lovastatin is independent of ras function.
DeClue, J. E., Vass, W. C., Papageorge, A. G., Lowy, D. R., & Willumsen, B. M. (1991) · PubMed · Cited by 131
Protein prenylation: key to ras function and cancer intervention?
Khosravi‐Far, R., Cox, A. D., Kato, K., & Der, C. J. (1992) · PubMed · Cited by 130
Vincent, L., Soria, C., Mirshahi, F., Opolon, P., Mishal, Z., Vannier, J., Soria, J., & Li, H. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000012283.15789.67 · Cited by 129
Lins, R. L., Matthys, K. E., Verpooten, G. A., Peeters, P. C., Dratwa, M., Stolear, J.-C., & Lameire, N. H. (2003) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg048 · Cited by 128
Clinical pharmacology of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors
Moghadasian, M. H. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00199-x · Cited by 128
Döppenschmitt, S., Spahn-Langguth, H., Regårdh, C. G., & Langguth, P. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js980378j · Cited by 127
Sivaprasad, U., Abbas, T., & Dutta, A. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0175 · Cited by 127
Effect of Statins on Fasting Plasma Glucose in Diabetic and Nondiabetic Patients
Sukhija, R., Prayaga, S., Marashdeh, M., Bursac, Z., Kakar, P., Bansal, D., Sachdeva, R., Kesan, S. H., & Mehta, J. L. (2009) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e318197ec8b · Cited by 126
Interactions with hydroxymethylglutaryl-coenzyme A reductase inhibitors
Garnett, W. R. (1995) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/52.15.1639 · Cited by 125
Simvastatin promotes angiogenesis and prevents microvascular remodeling in chronic renal ischemia
Chade, A., Zhu, X., Mushin, O. P., Claudio Napoli, A., Lerman, A., & Lerman, L. O. (2006) · The FASEB Journal · doi:10.1096/fj.05-5680fje · Cited by 125
Interaction of Oral Antidiabetic Drugs With Hepatic Uptake Transporters
Bachmakov, I., Glaeser, H., Fromm, M. F., & König, J. (2008) · Diabetes · doi:10.2337/db07-1515 · Cited by 125
Bottorff, M. B., & Hansten, P. D. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.15.2273 · Cited by 124
Tong, X.-K., Nicolakakis, N., Fernandes, P., Ongali, B., Brouillette, J., Quirion, R., & Hamel, E. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.06.003 · Cited by 122
Koyutürk, M., Ersöz, M., & Altıok, N. (2006) · Cancer Letters · doi:10.1016/j.canlet.2006.10.009 · Cited by 122
Araújo, F. D. A., Rocha, M. A., Mendes, J. B., & Andrade, S. P. (2009) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2009.03.003 · Cited by 122
Statin Use and Risk of Colorectal Cancer
Coogan, P. F., Smith, J., & Rosenberg, L. A. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk003 · Cited by 122
A multicolor flow cytometric assay for measurement of platelet-derived microparticles
Mobarrez, F., Antović, J. P., Egberg, N., Hansson, M., Jörneskog, G., Hultenby, K. R., & Wallén, H. (2009) · Thrombosis Research · doi:10.1016/j.thromres.2009.10.006 · Cited by 122
Clinical pharmacokinetics of statins
Garcia, M. J., Reinoso, R. F., Sanchez Navarro, A., & Prous, J. R. (2003) · Methods and Findings in Experimental and Clinical Pharmacology · doi:10.1358/mf.2003.25.6.769652 · Cited by 121
COMBINING BETA INTERFERON AND ATORVASTATIN MAY INCREASE DISEASE ACTIVITY IN MULTIPLE SCLEROSIS
Salvatore, E., Morra, V. B., & Orefice, G. (2009) · Neurology · doi:10.1212/wnl.0b013e3181ab6e08 · Cited by 121
Denoyelle, C., Albanese, P., Uzan, G., Li, H., Vannier, J., Soria, J., & Soria, C. (2003) · Cellular Signalling · doi:10.1016/s0898-6568(02)00124-9 · Cited by 120
Yavuz, B., Ertuğrul, D. T., Cil, H., Ata, N., Akın, K. O., Yalçın, A. A., Küçükazman, M., Dal, K., Hokkaomeroglu, M. S., Yavuz, B. B., et al. (2009) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-009-6181-8 · Cited by 120
Nübel, T., Dippold, W. G., Kleinert, H., Kaina, B., & Fritz, G. (2003) · The FASEB Journal · doi:10.1096/fj.03-0261fje · Cited by 119
Martín-Ventura, J. L., Blanco‐Colio, L. M., Gómez‐Hernández, A., Muñoz‐García, B., Vega, M., Serrano, J., Ortega, L. M., Hernández, G., Tuñón, J., & Egido, J. (2005) · Stroke · doi:10.1161/01.str.0000174289.34110.b0 · Cited by 117
Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis
Birnbaum, G., Cree, B., Altafullah, I., Zinser, M., & Reder, A. T. (2008) · Neurology · doi:10.1212/01.wnl.0000319698.40024.1c · Cited by 117
G Proteins in Cancer: The Prostate Cancer Paradigm
Daaka, Y. (2004) · Science s STKE · doi:10.1126/stke.2162004re2 · Cited by 116
Inoue, I., Itoh, F., Aoyagi, S., Tazawa, S., Kusama, H., Akahane, M., Mastunaga, T., Hayashi, K., Awata, T., Komoda, T., et al. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.6141 · Cited by 116
Inhibition of LOX-1 by Statins May Relate to Upregulation of eNOS
Mehta, J. L., Li, D. Y., Chen, H. J., Joseph, J., & Romeo, F. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.6070 · Cited by 115
The role of ADP-ribosylation factor and SAR1 in vesicular trafficking in plants
Memon, A. R. (2004) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2004.04.005 · Cited by 115
Roles of the PI-3K and MEK pathways in Ras-mediated chemoresistance in breast cancer cells
Jin, W., Wu, L., Liang, K., Liu, B., Lü, Y., & Fan, Z. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601048 · Cited by 115
Effect of itraconazole on the pharmacokinetics of rosuvastatin
Cooper, K. D. (2003) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(02)17633-8 · Cited by 115
Ahn, K. S., Sethi, G., & Aggarwal, B. B. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.10.010 · Cited by 114
Grana, T. M., Rusyn, E. V., Zhou, H., Sartor, C. I., & Cox, A. D. (2002) · PubMed · Cited by 114
Niemi, M., Neuvonen, P. J., & Kivistö, K. T. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.116511 · Cited by 113
Mehra, M. R., Uber, P. A., Vivekananthan, K., Solis, S., Scott, R. L., Park, M., Milani, R. V., & Lavie, C. J. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02340-9 · Cited by 112
Regression of chronic hypoxic pulmonary hypertension by simvastatin
Girgis, R. E., Mozammel, S., Champion, H. C., Li, D., Peng, X., Shimoda, L. A., Tuder, R. M., Johns, R. A., & Hassoun, P. M. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00411.2006 · Cited by 111
Contribution of cytochrome P450 3A4 and 3A5 to the metabolism of atorvastatin
Park, J.-E., Kim, K.-B., Bae, S. K., Moon, B., Liu, K., & Shin, J. (2008) · Xenobiotica · doi:10.1080/00498250802334391 · Cited by 110
Semb, A. G., van Wissen, S., Ueland, T., Smilde, T. J., Wæhre, T., Trip, M. D., Frøland, S. S., Kastelein, J. J. P., Gullestad, L. L., Pedersen, T. R., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02718-3 · Cited by 110
Ahn, K. S., Sethi, G., Chaturvedi, M. M., & Aggarwal, B. B. (2008) · International Journal of Cancer · doi:10.1002/ijc.23745 · Cited by 109
Rosuvastatin: a highly efficacious statin for the treatment of dyslipidaemia
Davidson, M. H. (2002) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.11.1.125 · Cited by 109
Xiao, H., Zhang, Q., Lin, Y. Q., Reddy, B. S., & Yang, C. S. (2008) · International Journal of Cancer · doi:10.1002/ijc.23315 · Cited by 108
Graf, H., Jüngst, C., Straub, G., Dogan, S., Hoffmann, R., Jakobs, T. F., Reiser, M. F., Waggershauser, T., Helmberger, T. K., Walter, A., et al. (2008) · Digestion · doi:10.1159/000156702 · Cited by 108
Carbamazepine markedly reduces serum concentrations of simvastatin and simvastatin acid
Uçar, M., Neuvonen, M., Luurila, H., Dahlqvist, R., Neuvonen, P. J., & Mj�rndal, T. (2004) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-003-0700-5 · Cited by 107
Piermartiri, T., Figueiredo, C. P., Rial, D., Duarte, F. S., Bezerra, S. C., Mancini, G., Bem, A. F. D., Prediger, R. D., & Tasca, C. I. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.08.030 · Cited by 107
Reddy, B. S., Wang, C. X., Kong, A. T., Khor, T. O., Zheng, X., Steele, V. E., Kopelovich, L., & Rao, C. V. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4428 · Cited by 106
Wæhre, T., Damås, J. K., Gullestad, L. L., Holm, A. M., Pedersen, T. R., Arnesen, K. E., Torsvik, H., Frøland, S. S., Semb, A. G., & Aukrust, P. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00263-8 · Cited by 105
Dimitroulakos, J., & Yeger, H. (1996) · Nature Medicine · doi:10.1038/nm0396-326 · Cited by 104
RAMCHARAN, A. S., van Stralen, K. J., Snoep, J. D., Mantel-Teeuwisse, A. K., Rosendaal, F. R., & Doggen, C. J. M. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.03235.x · Cited by 104
Ali, F., Zakkar, M., Karu, K., Lidington, E. A., Hamdulay, S., Boyle, J. J., Zloh, M., Bauer, A., Haskard, D. O., Evans, P. C., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.009886 · Cited by 104
Bone, H. G., Kiel, D. P., Lindsay, R. S., Lewiecki, E. M., Bolognese, M. A., Leary, E. T., Lowe, W., & McClung, M. R. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1909 · Cited by 104
Järvisalo, M. J., Toikka, J., Vasankari, T. J., Mikkola, J., Viikari, J. S. A., Hartiala, J., & Raitakari, O. T. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00189-6 · Cited by 102
Time‐dependent effect of statins on platelet function in hypercholesterolaemia
Puccetti, L., Pasqui, A. L., Pastorelli, M., Bova, G., Cercignani, M., Palazzuoli, A., Angori, P., Auteri, A., & Bruni, F. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.01086.x · Cited by 102
Estrogen Receptor–Negative Breast Cancer Is Less Likely to Arise among Lipophilic Statin Users
Kumar, A. S., Benz, C. C., Shim, V., Minami, C. A., Moore, D. H., & Esserman, L. J. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0726 · Cited by 102
Targeting the Mevalonate Pathway Inhibits the Function of the Epidermal Growth Factor Receptor
Mantha, A. J., Hanson, J. E. L., Goss, G., Lagarde, A. E., Lorimer, I. A., & Dimitroulakos, J. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1951 · Cited by 101
Knox, J. J., Siu, L. L., Chen, E. X., Dimitroulakos, J., Kamel‐Reid, S., Moore, M. J., Chin, S. F., Irish, J., Laframboise, S., & Oza, A. M. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2004.12.013 · Cited by 101
Zeiser, R., Youssef, S., Baker, J. B., Kambham, N., Steinman, L., & Negrin, R. S. (2007) · Blood · doi:10.1182/blood-2007-08-106005 · Cited by 99
Kurata, T., Miyazaki, K., Kozuki, M., Panin, V.-L., Morimoto, N., Ohta, Y., Nagai, M., Ikeda, Y., Matsuura, T., & Abe, K. (2011) · Brain Research · doi:10.1016/j.brainres.2010.11.067 · Cited by 98
Cilla, D. D., Gibson, D. M., Whitfield, L. R., & Sedman, A. J. (1996) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1996.tb04224.x · Cited by 98
Lipid rafts and the initiation of T cell receptor signaling
He, H., Lellouch, A. C., & Marguet, D. (2004) · Seminars in Immunology · doi:10.1016/j.smim.2004.09.001 · Cited by 98
Uptake of rosuvastatin by isolated rat hepatocytes: comparison with pravastatin
Nezasa, K.-I., Higaki, K., Takeuchi, M., Nakano, M., & Koike, M. (2003) · Xenobiotica · doi:10.1080/0049825031000066259 · Cited by 98
Frick, M., Dulak, J., Cisowski, J., Józkowicz, A., Zwick, R. H., Alber, H. F., Dichtl, W., Schwarzacher, S. P., Pachinger, O. M., & Weidinger, F. F. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00299-5 · Cited by 97
The endocytic catalysts, Rab5a and Rab7, are tandem regulators of thyroid hormone production
Croizet-Berger, K., Daumerie, C., COUVREUR, M., Courtoy, P. J., & van den Hove, M.-F. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122187699 · Cited by 97
Fujino, H., Yamada, I., Shimada, S., Yoneda, M., & Kojima, J. (2003) · Xenobiotica · doi:10.1080/0049825021000017957 · Cited by 96
Therapeutic potential of lovastatin in multiple sclerosis
Sena, A., Pedrosa, R., & Morais, M. G. (2003) · Journal of Neurology · doi:10.1007/s00415-003-1070-8 · Cited by 96
Cardiovascular Disease Risk Factors and Cognitive Impairment
Nash, D. T., & Fillit, H. M. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.12.031 · Cited by 93
Roudier, E. A., Mistafa, O., & Stenius, U. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0352 · Cited by 92
Yamamoto, A., Hoshi, K., & Ichihara, K. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00692-x · Cited by 91
Effect of Age and Gender on Pharmacokinetics of Atorvastatin in Humans
Gibson, D. M., Bron, N. J., Richens, M. A., Hounslow, N. J., Sedman, A. J., & Whitfield, L. R. (1996) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1996.tb04194.x · Cited by 90
Clinical Pharmacokinetics of Pravastatin
Quion, A. V., & Jones, P. H. (1994) · Clinical Pharmacokinetics · doi:10.2165/00003088-199427020-00002 · Cited by 90
Yang, Z., Xiao, H., Jin, H., Koo, P. T., Tsang, D. J., & Yang, C. S. (2009) · International Journal of Cancer · doi:10.1002/ijc.24766 · Cited by 90
Simvastatin Protects against the Development of Endometriosis in a Nude Mouse Model
Bruner‐Tran, K. L., Osteen, K. G., & Dulęba, A. J. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2802 · Cited by 90
Statins and Cancer Development
Duncan, R. E., El‐Sohemy, A., & Archer, M. C. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0027 · Cited by 90
Kuipers, H. F., Biesta, P. J., Groothuis, T. A., Neefjes, J., Mommaas, A. M., & van den Elsen, P. J. (2005) · Human Immunology · doi:10.1016/j.humimm.2005.04.004 · Cited by 89
Rabex-5 Is a Rab22 Effector and Mediates a Rab22-Rab5 Signaling Cascade in Endocytosis
Zhu, H., Liang, Z., & Li, G. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e09-06-0453 · Cited by 89
Katz, M. S., Minsky, B. D., Saltz, L. B., Riedel, E., Chessin, D. B., & Guillem, J. G. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2004.12.033 · Cited by 88
Cholesterol and mevalonic acid modulation in cell metabolism and multiplication
Soma, M. R., Corsini, A., & Paoletti, R. (1992) · Toxicology Letters · doi:10.1016/0378-4274(92)90167-i · Cited by 87
Zhong, W.-B., Liang, Y.-C., Wang, C.-Y., Chang, T.-C., & Lee, W. S. (2005) · Endocrine Related Cancer · doi:10.1677/erc.1.01012 · Cited by 87
Pharmacokinetics of Fluvastatin and Specific Drug Interactions
Smith, H. T., Jokubaitis, L. A., Troendle, A. J., Hwang, D.-Y., & Robinson, W. T. (1993) · American Journal of Hypertension · doi:10.1093/ajh/6.11.375s · Cited by 86
NK-104: a novel synthetic HMG-CoA reductase inhibitor
Kajinami, K., Mabuchi, H., & Saito, Y. (2000) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.9.11.2653 · Cited by 85
Potentiated antitumour effects of cisplatin and lovastatin against MmB16 melanoma in mice
Feleszko, W., Zagożdżon, R., Gołąb, J., & Jakóbisiak, M. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(97)10034-x · Cited by 85
LaCroix, A. Z., Gray, S. L., Aragaki, A., Cochrane, B. B., Newman, A. B., Kooperberg, C. L., Black, H., Curb, J. D., Greenland, P., & Woods, N. F. (2008) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/63.4.369 · Cited by 84
Chuengsamarn, S., Rattanamongkolgul, S., Suwanwalaikorn, S., Wattanasirichaigoon, S., & Kaufman, L. (2010) · Bone · doi:10.1016/j.bone.2009.12.023 · Cited by 84
Biotransformation of fluvastatin sodium in humans.
Dain, J. G., Fu, E., Gorski, J. C., Nicoletti, J. M., & Scallen, T. J. (1993) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)07457-4 · Cited by 83
Synchronization of the cell cycle using Lovastatin
Javanmoghadam-Kamrani, S., & Keyomarsi, K. (2008) · Cell Cycle · doi:10.4161/cc.6364 · Cited by 83
Sata, M., Nishimatsu, H., Osuga, J.-I., Tanaka, K., Ishizaka, N., Ishibashi, S., Hirata, Y., & Nagai, R. (2004) · Hypertension · doi:10.1161/01.hyp.0000126186.29571.41 · Cited by 83
Welzenbach, K., Hommel, U., & Weitz‐Schmidt, G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110521200 · Cited by 82
Lee, J., Jung, K. H., Park, Y. S., Ahn, J. B., Shin, S. J., Im, S., Oh, D. Y., Shin, D. B., Kim, T. W., Lee, N.-S., et al. (2009) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0913-5 · Cited by 80
Suppressive Effects of Statins on Acute Promyelocytic Leukemia Cells
Sassano, A., Katsoulidis, E., Antico, G., Altman, J. K., Redig, A. J., Minucci, S., Tallman, M. S., & Platanias, L. C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3686 · Cited by 80
Atorvastatin and Celecoxib Inhibit Prostate PC-3 Tumors in Immunodeficient Mice
Zheng, X., Cui, X., Avila, G. E., Huang, M., Liu, Y., Patel, J. A., Kong, A. N. T., Paulino, R., Shih, W. J., Lin, Y., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0242 · Cited by 79
Synergistic interaction of lovastatin and paclitaxel in human cancer cells.
Holstein, S. A., & Hohl, R. J. (2001) · PubMed · Cited by 79
HMG CoA reductase inhibitors and the risk of venous thrombosis among postmenopausal women
Doggen, C. J. M., Lemaître, R. N., Smith, N. L., Heckbert, S. R., & Psaty, B. M. (2004) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2004.00696.x · Cited by 78
Tissue selectivity of hydroxymethylglutaryl coenzyme a (HMG CoA) reductase inhibitors
Sirtori, C. R. (1993) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(93)90031-8 · Cited by 77
Platelet Cytosolic Ca 2+ and Membrane Dynamics in Patients With Primary Hypercholesterolemia
Sang, K. L. Q., Levenson, J. A., Mégnien, J. L., Simon, A. C., & Devynck, M. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.6.759 · Cited by 77
Werner, M., Sacher, J., & HOHENEGGER, M. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705928 · Cited by 76
Abrogation of Insulin-like Growth Factor-I (IGF-I) and Insulin Action by Mevalonic Acid Depletion
Siddals, K. W., Marshman, E., Westwood, M., & Gibson, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404838200 · Cited by 76
Scranton, R. E., Young, M., Lawler, E. V., Solomon, D. H., GAGNON, D. R., & Gaziano, J. M. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.17.2007 · Cited by 76
Bocci, G., Fioravanti, A., Orlandi, P., Bernardini, N., Collecchi, P., Tacca, M. D., & Danesi, R. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602720 · Cited by 75
Statins and the risk of idiopathic venous thromboembolism
Yang, C., Jick, S. S., & Jick, H. (2002) · British Journal of Clinical Pharmacology · doi:10.1046/j.0306-5251.2001.01523.x · Cited by 74
Narisawa, T., Fukaura, Y., Terada, K., et al. (1994) · Carcinogenesis · doi:10.1093/carcin/15.9.2045 · Cited by 74
Cholesterol modulates cellular TGF‐β responsiveness by altering TGF‐β binding to TGF‐β receptors
Chen, C., Huang, S. S., & Huang, J. S. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21303 · Cited by 74
Sadeghi, M. M., Tiglio, A., Sadigh, K., Donnell, L. O., Collinge, M., Pardi, R., & Bender, J. R. (2001) · Transplantation · doi:10.1097/00007890-200105150-00014 · Cited by 74
Does Statin Therapy Decrease the Risk for Bleeding in Patients Who Are Receiving Warfarin?
Douketis, J. D., Melo, M., Bell, C. M., et al. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.06.008 · Cited by 74
Comparative Effects of Fibrates on Drug Metabolizing Enzymes in Human Hepatocytes
Prueksaritanont, T., Richards, K. M., Qiu, Y., Strong-Basalyga, K., Miller, A. R., Li, C., Eisenhandler, R., & Carlini, E. J. (2005) · Pharmaceutical Research · doi:10.1007/s11095-004-9011-5 · Cited by 73
Lovastatin‐induced up‐regulation of the BH3‐only protein, Bim, and cell death in glioblastoma cells
Jiang, Z., Zheng, X.-F., Lytle, R. A., Higashikubo, R., & Rich, K. M. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02319.x · Cited by 73
Isoprenoid modification permits 2′,3′‐cyclic nucleotide 3′‐phosphodiesterase to bind to membranes
Braun, P. E., Angelis, D. A. D., Shtybel, W. W., & Bernier, L. (1991) · Journal of Neuroscience Research · doi:10.1002/jnr.490300311 · Cited by 73
Kimura, T., Kaneko, Y. K., Yamada, S., Ishihara, H., Senda, T., Iwamatsu, A., & Niki, I. (2008) · Journal of Cell Science · doi:10.1242/jcs.030544 · Cited by 72
Suppression of Autoimmune Retinal Disease by Lovastatin Does Not Require Th2 Cytokine Induction
Gegg, M. E., Harry, R. A., Hankey, D. J. R., Zambarakji, H., Pryce, G., Baker, D., Adamson, P., Calder, V. L., & Greenwood, J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.4.2327 · Cited by 71
Stirewalt, D. L., Appelbaum, F. R., Willman, C. L., Zager, R. A., & Banker, D. E. (2003) · Leukemia Research · doi:10.1016/s0145-2126(02)00085-1 · Cited by 71
Deschaseaux, F., Selmani, Z., Falcoz, P., Mersin, N., Meneveau, N. F., Penfornis, A., Kleinclauss, C., Chocron, S., Etievent, J.-P., Tiberghien, P., et al. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.01.045 · Cited by 71
Pharmacodynamic interaction between ezetimibe and rosuvastatin
Kosoglou, T., Statkevich, P., Yang, B., Suresh, R., Zhu, Y., Boutros, T., Maxwell, S. E., Tiessen, R. G., & Cutler, D. L. (2004) · Current Medical Research and Opinion · doi:10.1185/030079904125004213 · Cited by 71
Wang, I.-K., Lin‐Shiau, S., & Lin, J. (2000) · Oncology · doi:10.1159/000012168 · Cited by 70
Immunomodulation by statins: mechanisms and potential impact on autoimmune diseases
Chow, S. C. (2009) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-009-0038-5 · Cited by 69
Leone, A. M., Rutella, S., Giannico, M. B., Perfetti, M., Zaccone, V., Brugaletta, S., Garramone, B., Niccoli, G., Porto, I., Liuzzo, G., et al. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2008.05.036 · Cited by 69
Physiological Disposition of Hmg-Coa-Reductase Inhibitors
Duggan, D. E., & Vickers, S. (1990) · Drug Metabolism Reviews · doi:10.3109/03602539009041088 · Cited by 69
Kaji, H., Kanatani, M., Sugimoto, T., et al. (2005) · Hormone and Metabolic Research · doi:10.1055/s-2005-870538 · Cited by 68
Haramaki, N., Ikeda, H., Takenaka, K., Katoh, A., Sugano, R., Yamagishi, S., Matsuoka, H., & Imaizumi, T. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.106.128793 · Cited by 68
Virdis, A., Colucci, R., Versari, D., Ghisu, N., Fornai, M., Antonioli, L., Duranti, E., Daghini, E., Giannarelli, C., Blandizzi, C., et al. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.132258 · Cited by 67
Lacut, K., Oger, E., Gal, G. L., et al. (2004) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2004.00252.x · Cited by 66
Narisawa, T., Morotomi, M., Fukaura, Y., Hasebe, M., Ito, M., & Aizawa, R. (1996) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1996.tb02103.x · Cited by 66
Association between risk of myopathy and cholesterol-lowering effect: A comparison of all statins
Kobayashi, M., Chisaki, I., Narumi, K., Hidaka, K., Kagawa, T., Itagaki, S., Hirano, T., & Iseki, K. (2008) · Life Sciences · doi:10.1016/j.lfs.2008.02.019 · Cited by 66
Calza, L., Manfredi, R., Colangeli, V., Pocaterra, D., Pavoni, M., & Chiodo, F. (2008) · Current HIV Research · doi:10.2174/157016208786501481 · Cited by 66
Miida, T., Takahashi, A., & Ikeuchi, T. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.09.003 · Cited by 66
Heeba, G. H., & Abd‐Elghany, M. I. (2010) · Phytomedicine · doi:10.1016/j.phymed.2010.04.007 · Cited by 65
Launay‐Vacher, V., Izzedine, H., & Deray, G. (2004) · International Journal of Cardiology · doi:10.1016/j.ijcard.2004.04.005 · Cited by 65
Serebruany, V. L., Miller, M. J., Pokov, A. N., Malinin, A. I., Lowry, D. R., Tanguay, J., & Hennekens, C. H. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.11.058 · Cited by 65
Fluvastatin inhibits raft dependent Fcγ receptor signalling in human monocytes
Hillyard, D. Z. (2003) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2003.11.004 · Cited by 64
ck, W. M. (1998) · Drugs · doi:10.2165/00003495-199856001-00003 · Cited by 64
Hughes, A., Rogers, M. J., Idris, A. I., & Crockett, J. C. (2007) · Calcified Tissue International · doi:10.1007/s00223-007-9078-1 · Cited by 64
Cemeus, C., Zhao, T., Barrett, G. M., Lorimer, I. A. J., & Dimitroulakos, J. (2008) · Journal of Neuro-Oncology · doi:10.1007/s11060-008-9627-0 · Cited by 63
Kaji, H., Naito, J., Inoue, Y., Sowa, H., Sugimoto, T., & Chihara, K. (2008) · Hormone and Metabolic Research · doi:10.1055/s-0028-1082051 · Cited by 63
Clutterbuck, R. D., Millar, B. C., Powles, R., et al. (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00783.x · Cited by 63
Effect of Food on the Bioavailability of Atorvastatin, an HMG‐CoA Reductase Inhibitor
Radulovic, L. L., Cilla, D. D., Posvar, E. L., et al. (1995) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1995.tb04015.x · Cited by 63
Interaction of cytosine arabinoside and lovastatin in human leukemia cells
Holstein, S. A., & Hohl, R. J. (2001) · Leukemia Research · doi:10.1016/s0145-2126(00)00162-4 · Cited by 63
Jaschke, B., Michaelis, C., Milz, S., Vogeser, M., Mund, T., Hengst, L., Kastrati, A., Schömig, A., & Wessely, R. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.06.029 · Cited by 62
Rosuvastatin Reduces Platelet Activation in Heart Failure
Schäfer, A., Fraccarollo, D., Eigenthaler, M., Tas, P. W. L., Firnschild, A., Frantz, S., Ertl, G., & Bauersachs, J. K. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000161926.43967.df · Cited by 61
Saito, A., Saito, N., Mol, W., Furukawa, H., Tsutsumida, A., Oyama, A., Sekido, M., Sasaki, S., & Yamamoto, Y. (2008) · Melanoma Research · doi:10.1097/cmr.0b013e3282f60097 · Cited by 60
Effect of HMG-CoA reductase inhibitors on vascular cell apoptosis: Beneficial or detrimental?
Katsiki, N., Τζιόμαλος, Κ., Chatzizisis, Y. S., Elisaf, M., & Hatzitolios, A. I. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.12.028 · Cited by 60
Watała, C. W., Boncler, M. A., & Grešner, P. (2005) · PubMed · Cited by 60
CYR61 downregulation reduces osteosarcoma cell invasion, migration, and metastasis
Fromigué, O., Hamidouche, Z., Vaudin, P., Lecanda, F., Patiño‐García, A., Barbry, P., Mari, B. P., & Marie, P. J. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.343 · Cited by 59
Wang, I.-K., Lin‐Shiau, S., & Lin, J. (2000) · Pharmacology & Toxicology · doi:10.1034/j.1600-0773.2000.d01-16.x · Cited by 59
Zhang, S., Rahman, M., Zhang, S., Qi, Z., & Thorlacius, H. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.0510279 · Cited by 59
Statins increase the risk of prostate cancer: A population‐based case–control study
Chang, C., Ho, S., Chiu, H., & Yang, C. (2011) · The Prostate · doi:10.1002/pros.21401 · Cited by 58
Statins Decrease the Occurrence of Venous Thromboembolism in Patients with Cancer
Khemasuwan, D., DiVietro, M. L., Tangdhanakanond, K., Pomerantz, S. C., & Eiger, G. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.05.025 · Cited by 58
Endothelial Progenitor Cells: Therapeutic Target for Cardiovascular Diseases
Umemura, T., & Higashi, Y. (2008) · Journal of Pharmacological Sciences · doi:10.1254/jphs.08r01cp · Cited by 58
Cheng, H., Rogers, J. D., Sweany, A. E., Dobrinska, M. R., Stein, E. A., Tate, A. C., Amin, R. D., & Quan, H. (1992) · Pharmaceutical Research · doi:10.1023/a:1015828811865 · Cited by 57
Minden, M. D., Dimitroulakos, J., Nohynek, D., & Penn, L. Z. (2001) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428190109097663 · Cited by 57
Wang, H., Li, J., Huang, C.-X., & Jiang, H. (2004) · Clinica Chimica Acta · doi:10.1016/j.cccn.2004.10.007 · Cited by 57
Effects of statins on early and late results of carotid stenting
Verzini, F., Rango, P. D., Parlani, G., Giordano, G., Caso, V., Cieri, E., Isernia, G., & Cao, P. (2010) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2010.08.024 · Cited by 56
Simvastatin-diltiazem drug interaction resulting in rhabdomyolysis and hepatitis.
Kanathur, N., Mathai, M. G., Byrd, R. P., et al. (2001) · PubMed · Cited by 55
Critical appraisal of the role of pitavastatin in treating dyslipidemias and achieving lipid goals
Saitō, Y. (2009) · Vascular Health and Risk Management · doi:10.2147/vhrm.s5551 · Cited by 54
Bartoli, M., Al‐Shabrawey, M., Labazi, M., Behzadian, M. A., Istanboli, M., El‐Remessy, A. B., Caldwell, R. W., Marcus, D. M., & Caldwell, R. B. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-2158 · Cited by 54
Effect of food on pravastatin pharmacokinetics and pharmacodynamics.
Pan, H. Y., Devault, A., Brescia, D. J., Willard, D. A., McGovern, M. E., Whigan, D. B., & Ivashkiv, E. (1993) · PubMed · Cited by 53
Makabe, S., Takahashi, Y., Watanabe, H., Murakami, M., Ohba, T., & Ito, H. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.07.059 · Cited by 53
Atorvastatin reduces platelet‐oxidized‐LDL receptor expression in hypercholesterolaemic patients
Puccetti, L., Sawamura, T., Pasqui, A. L., Pastorelli, M., Auteri, A., & Bruni, F. (2005) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2005.01446.x · Cited by 53
Lovastatin modulation of microglial activation via suppression of functional CD40 expression
Townsend, K. P., Shytle, D., Bai, Y., San, N., Zeng, J., Freeman, M. J., Mori, T., Fernandez, F., Morgan, D., Sanberg, P. R., et al. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20234 · Cited by 53
Biophysical Analysis of the Interaction of Rab6a GTPase with Its Effector Domains
Bergbrede, T., Chu, N. K., Schoebel, S., Blankenfeldt, W., Geyer, M., Fuchs, E., Goody, R. S., Barr, F. A., & Alexandrov, K. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806003200 · Cited by 53
Liuni, A., Luca, M. C., Gori, T., & Parker, J. D. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.11.046 · Cited by 53
Opper, C., Clement, C., Schwarz, H., Krappe, J., Steinmetz, A., Schneider, J. E., & Wesemann, W. (1995) · Atherosclerosis · doi:10.1016/0021-9150(94)05448-r · Cited by 53
Absolute and relative bioavailability of the HMG-CoA reductase inhibitor cerivastatin.
Mück, W. M., Ritter, W., Ochmann, K., Unger, S., Ahr, G., Wingender, W., & Kuhlmann, J. (1997) · PubMed · Cited by 53
Cited by
Global Epidemiology of Hepatocellular Carcinoma
McGlynn, K. A., Petrick, J. L., & London, W. T. (2015) · Clinics in Liver Disease · doi:10.1016/j.cld.2015.01.001 · Cited by 908
Multi-Organ toxicity demonstration in a functional human in vitro system composed of four organs
Oleaga, C., Bernabini, C., Smith, A. S. T., Srinivasan, B., Jackson, M., McLamb, W., Platt, V., Bridges, R., Cai, Y., Santhanam, N., et al. (2016) · Scientific Reports · doi:10.1038/srep20030 · Cited by 442
Triple-negative breast cancer: is there a treatment on the horizon?
Yao, H., He, G., Yan, S., Chen, C., Song, L., Rosol, T. J., & Deng, X. (2017) · Oncotarget · doi:10.18632/oncotarget.12284 · Cited by 394
Alam, M. A., Subhan, N., Hossain, H., Hossain, M., Reza, H. M., Rahman, M. M., & Ullah, M. O. (2016) · Nutrition & Metabolism · doi:10.1186/s12986-016-0080-3 · Cited by 359
The Innovative Potential of Statins in Cancer: New Targets for New Therapies
Di Bello, E., Zwergel, C., Mai, A., & Valente, S. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.00516 · Cited by 105
Metadata
- Authors
- Gazzerro, P., Proto, M. C., Gangemi, G., Malfitano, A. M., Ciaglia, E., Pisanti, S., Santoro, A., Laezza, C., & Bifulco, M.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2012-01
- Volume
- 64
- Issue
- 1
- Pages
- 102-146
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W2146546690
- Cited by
- 457
- References
- 492
- FWCI
- 6.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.